Mukund Paravasthu, Chief Operating Officer at NovoCure Ltd (NVCR), sold 2,014 shares at $18.28 ($40K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Open-market sale of $40k NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.92 | 1,379 | $27K | 69.2% |
| 2 | $20.55 | 267 | $5K | 13.8% |
| 3 | $18.28 | 368 | $7K | 17.0% |
| Total | $19.70 avg | 2,014 | $40K | 100% |
| Filing → |
| NVCR | SELL | 2025-05-05 | $11K | — | Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-01-15 | $116K | — | Filing → |